Medlr Leuko's Non-Invasive Device Revolutionizes Chemotherapy Monitoring MIT spinoff Leuko introduces a groundbreaking non-invasive device to monitor white blood cell levels in chemotherapy patients. Using light and AI technology, this device aims to enhance patient comfort and revolutionize cancer treatment by enabling personalized chemotherapy dosages.
News Andhra Teacher Achieves Cancer Remission with CAR-T Cell Therapy A teacher from Visakhapatnam, Andhra Pradesh, has achieved complete cancer remission following CAR-T cell therapy, a significant development for the state. Ms. Reddi Lalitha Kumari's aggressive lymphoma did not respond to conventional treatments.
News AstraZeneca’s Trastuzumab Deruxtecan Receives CDSCO Approval for Expanded Use AstraZeneca's Trastuzumab deruxtecan has been approved in India for the treatment of adult patients with unresectable or metastatic HER2-Low breast cancer post-chemotherapy, as well as for individuals with HER2-positive gastric or gastroesophageal cancer following a trastuzumab-based regimen.
News Tata Institute Breakthrough: New Drug Claims to Prevent Cancer Recurrence and Reduce Treatment Side Effects Researchers at Tata Institute in Mumbai have developed a promising new cancer drug in tablet form. This innovative drug, called R+Cu, has shown effectiveness in preventing cancer recurrence and significantly reducing side effects from traditional treatments like chemotherapy and radiation.
News Histotripsy Receives FDA Nod For Liver Cancer Treatment Histotripsy, a pioneering technology developed at the University of Michigan, has received FDA approval for the treatment of liver tumors. HistoSonics, the company behind this innovative approach, can now offer its histotripsy delivery platform.
News Hydrogel-Based Chemotherapy Enhancement and pH Regulation Hydrogel-Based Chemotherapy Enhancement and pH Regulation represent a groundbreaking approach to cancer treatment. By leveraging hydrogel technology, we can enhance the effectiveness of chemotherapy while simultaneously regulating the pH environment within the tumor.
News Government Initiated Chemotherapy at 30 ESIC Hospitals The government has taken a significant step in healthcare by initiating chemotherapy services at 30 ESIC (Employees' State Insurance Corporation) hospitals, expanding access to critical cancer treatment for patients across the country.
